Diabetic retinopathy
Conditions
Interventions
Intervention group:Intraoperative dexamethasone sustained release implant
Observation Group:none
Sponsors
Beijing aier intech eye hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Will be carried out in Beijing Eyre Yingzhi Eye Hospital and Beijing Union Hospital ophthalmology. Women and men diagnosed as PDR with DME or silicone oil filled eyes with DME, DME with macular center (defined as 300 um) can be studied in groups after the therapist decides to use dexamethasone sustained-release implant (Ozurdex) for treatment. Indications and contraindications approved according to the local market should be carefully considered. All patients enrolled in the study must be prospectively recorded. Before entering any data into the case report form (CRF), an informed consent is required.
Exclusion criteria
Exclusion criteria: Accompanied by other than PDR fundus disease or optic nerve disease, glaucoma disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Macular fovea thickness; | — |
Secondary
| Measure | Time frame |
|---|---|
| Best corrected visual acuity; | — |
Countries
China
Contacts
Public ContactGu Wei
Beijing Aier Intech Eye Hospital
Outcome results
None listed